Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and...
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Objectives
To assess the therapeutic response to brolucizumab and aflibercept by deep learning/OCT-based analysis of macular fluid volumes in neovascular age-related macular degeneration.
Methods
In this post-hoc analysis of two phase III, randomised, multi-centre studies (HAWK/HARRIER), 1078 and 739 treatment-naive eyes receiving broluciz...
Alternative Titles
Full title
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10101971
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10101971
Other Identifiers
ISSN
0950-222X
E-ISSN
1476-5454
DOI
10.1038/s41433-022-02077-4
